My own rapid response to the BMJ article by Professor Grundy. It may not get published but I am posting it here, anyway.
)
Kind regards,
xrn
Is Professor Scott M Grundy really serious? At the end of his article is the following under the heading; Competing interest: SMG has been a consultant to the following companies that market statins: Merck, Pfizer, Bristol Myers Squibb, and Astra Zeneca.
Can I be alone in thinking that these particular associations, with the avaricious and predatory pharmaceutical industry, must surely render Professor Grundy's publicly stated professional opinions (concerning statins) as effectively worthless.
While Professor Grundy is fully entitled to hold a viewpoint on the subject, it is most unseemly, that he should be regarded as an opinion leader for statin therapy, especially where the pharmaceutical industry have paid him to promote their products. It is also probable that any patient he prescribes statins for, who goes on to subsequently develop any form of 'statin disease', would have a legal case against him because Professor Grundy would have to show that he had arrived at the decision in an unbiased manner.
Professor Grundy has a long (and presumably lucrative association) with not just one but four of the major statin producing pharmaceutical companies, who have each engaged him as a consultant, one assumes to advocate on the behalf of statins. By dint of which rule should I ignore this association and the influence it is certain to have on Professor Grundy's pronouncements about statin therapy?
This astonishing competing interest declaration suggests to me that Professor Grundy ought to find a new area of interest so that he can avoid making public statements about statin therapy, that cannot be considered to be anything other than tainted and therefore worthless. I am saddened to see yet another medical talent fall in this way and become just another statistic for the medics who are lost to the world of big business.